Research into Peptides
Your direct source for raw data, clinical breakdowns, and industry updates on the frontier of peptide science.
*For research purposes only - not for human consumption*
Hormone Vitality Research
Characterization of the Potent Growth Hormone-Releasing Activity of Hexarelin in Human Subjects: A Comparative Endocrine Evaluation
This foundational clinical study evaluated the direct potency of Hexarelin in comparison to native Growth Hormone-Releasing Hormone (GHRH), establishing its place as an elite-tier secretagogue.
The Phase 3 Clinical Trial for Visceral Fat Atrophy with Tesamorelin.
This landmark multi-center human trial evaluated Tesamorelin's ability to selectively eliminate dangerous, deep-belly fat (visceral adipose tissue) and reverse severe metabolic complications.
Pulsatile Secretion Kinetics and Endocrine Integrity Maintenance Following Intravenous and Subcutaneous Administration of Growth Hormone-Releasing Factor (GRF 1-29) in Human Subjects
This landmark clinical human study maps out how Sermorelin stimulates growth hormone release while cleanly preserving the natural physiological peaks and valleys of the endocrine system.
Receptor Selectivity and Endocrine Profiling of Ipamorelin: Characterization of Pulsatile Growth Hormone Release without Cortisol and Prolactin Stimulation
This landmark preclinical study established Ipamorelin as a first-of-its-kind selective growth hormone secretagogue that leaves other endocrine axes completely undisturbed.
GHRP-6’s effects on actively repairing cardiac tissue following a heart attack.
This recent study maps how GHRP-6 actively repairs cardiac tissue following a severe myocardial infarction (heart attack).
Synthetic Ghrelin Receptor Agonism via Growth Hormone-Releasing Peptide-2 (GHRP-2) Promotes Short-Term Hyperphagia and Escalated Caloric Intake in Healthy Men
This clinical human study tracks how GHRP-2 alters acute appetite and caloric intake in human adults.